|
| Exchange Disseminated Time 19/01/2018 11:29:51 | Suven Life Sciences Ltd has informed BSE that a Board Meeting of the Company will be held on January 30, 2018, inter alia, to consider and take on record the following matter(s):
1. To consider and approve the Un-audited Financial Results of the Company under Ind AS for the quarter and nine months ended December 31, 2017.
2. To consider declaration of Interim Dividend, if any, for the financial year 2017-18 and related matters etc. and
Further, TRADING WINDOW for dealing in the securities of the Company is closed from January 19, 2018 to February 01, 2018 (both days inclusive) as per PIT Code of the Company. Trading window will be opened from February 02, 2018. |
|
|